-
November 12, 2021, Zeesan Biotech’s HLA-B*58:01 gene detection kit (fluorescence PCR melting curve analysis) successfully received certification from NMPA (GXZZ 20213400934) after HLA-B*15:02 gene detection kit. Based on multicolor melting curve analysis (MMCA®), the kit is used for in vitro qua...Read more »
-
As the only preventable, controllable and treatable cancer, the prevention and treatment strategy of cervical cancer is always inseparable from several key words: HPV infection, vaccination, and regular screening. Data shows that cervical cancer is the third most common malignant tumor among wom...Read more »
-
Acute leukemia (AL) is a group of highly heterogeneous hematological malignancies, which can be mainly divided into acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and acute undifferentiated leukemia (mainly refers to mixed phenotype acute leukemia, MPAL). Among which, AML is th...Read more »
-
Introduction: CHANCE-2 study of the team of Prof. Wang Yongjun, Beijing Tiantan Hospital, Capital Medical University was published on The New England Journal of Medicine on October 28, 2021. Among patients with minor ischemic stroke (MIS) or transient ischemic attack(TIA) who were carriers of CY...Read more »
-
Real-time PCR Real-time PCR is the most widely used nucleic acid detection technology. The detection mode uses closed-tube detection, which greatly reduces the chance of amplification product contamination compared to open-tube detection, saves time and manpower, facilitates automation, an...Read more »
-
Relaxing by taking a bath but suffered from “hot tub lung disease”? Looking forward to a new look after a beauty treatment but didn’t expect to get a nightmare of purulent skin disease? Why a small cut by a shrimp but leads to amputation? Why did a common activity in life almos...Read more »
-
Chronic Myeloid Leukemia (hereinafter referred to as CML) is a malignancy caused by clonal proliferation of HSCs in bone marrow due to the BCR-ABL fusion gene formed by translocation of chromosomes 9 and 22 in the patient’s body. Its chemotherapy, radiotherapy, and other conventional therapies a...Read more »
-
Regarding the mutations in the latest variant of concern, Omicron-B.1.1.529, we would like to assure you that there is NO IMPACT to the accuracy or effectiveness of the current Zeesan assays for the detection of SARS-CoV-2. The result REMAINS RELIABLE. Omicron can be reliably detected in the fol...Read more »
-
According to Annual Report for National Adverse Drug Reactions Monitoring (2018), the National Adverse Drug Reaction Monitoring Network received 1.499 million copies of the Adverse Drug Reaction/Event Reporting Form [1]. The National ADR Monitoring Network cumulatively received 13.68 million cop...Read more »
-
On September 18, 2021, Zeesan’s MeltPro® HLA-B*15:02 Test received GXZZ 20213400740 certificate from NMPA. The multicolor melting curve analysis-based (MMCA®) test kit is used for determination of whether a patient carries HLA-B*15:02 gene through in vitro qualitative test, and population carry...Read more »
-
Established in June 2010, Zeesan is an innovative company with the underlying PCR technology. It has established “Multicolor Melting Curve Analysis”, “Magnetic Bead (MB)-based Nucleic Acid Extraction Platform” and “Automatic Instrumentation Integration Platform̶...Read more »
-
Introduction to SARS-CoV-2 variants Since the outbreak of the COVID-19, SARS-CoV-2 has continued to undergo mutations. According to reports, SARS-CoV-2 usually accumulates mutations at a rate of 1-2 mutations per month. This means that many of the SARS-CoV-2 genomes measured now are about 20 site...Read more »
-
In Brazil, from 3 January 2020 to 3:59pm CET, 22 March 2021, there have been 11,950,459 confirmed cases of COVID-19 with 292,752 deaths, reported to WHO. Since the outbreak of the COVID-19 epidemic, Xiamen Zeesan Biotech Co., Ltd. (referred to as “Zeesan Biotech”) has exported COVID-1...Read more »
-
In Brazil, from 3 January 2020 to 2:44pm CET, 10 March 2021, there have been 11,051,665 confirmed cases of COVID-19 with 266,398 deaths, reported to WHO. Since the outbreak of the COVID-19 epidemic, Xiamen Zeesan Biotech Co., Ltd. (referred to as “Zeesan Biotech”) has exported COVID-1...Read more »
-
Welcome to visit Zeesan Biotech at The 71st AACC Annual Scientific Meeting & Clinical Lab Expo Date: 4-8 August Stand No.: Hall B 3326 Location: Anaheim Convention Center, 800 W Katella Ave, Anaheim, CA 92802, United States About AACC Since 1949, American Association for Clinical Chemistry...Read more »
-
Welcome to visit Zeesan Biotech at MEDICA 2019 Date: 18-21 November Stand No.: Hall 1/G53 Location: Düsseldorf / Germany Products on show: Saliva DNA Sample collection kit: for DTC genetic testing Lab-Aid 824s DNA extraction system: Lab-Aid 824 upgraded version with high DNA concentration Leu...Read more »
-
October 12, to share recent developments in research and technology innovation, progress in TB diagnostics, prevention and anti-TB therapy in China, the Chinese Anti-tuberculosis Association held a Satellite Session during the 48th Union Conference on Lung Health in Guadalajara, Mexico. Zeesan Bi...Read more »
-
Welcome to visit Zeesan Biotech at Indonesian Int’l HOSPITAL 2017 . Date: 18-21 October Stand No.: HB-154 Venue: Jakarta Convention Center, Indonesia For further information, please contact info@zsandx.com. Read more »
-
This means that our complete set of COVID-19 nucleic acid test can now be exported. We have a full set of CE certificates and FSC, a full set of NMPA certificates except the detection reagents, and many of them have obtained FDA EUA. Welcome to inquire: 0086-592-7615091 / 18606098912(Wenhan Wang). Read more »
-
Annette Tumolo ,the Global President of Life Sciences Division of Bio-Rad Laboratories,Inc., along with Changhong,the Asia-PacificRegional Manager of Bio-Rad Laboratories,Inc., and their teammates visit Zeesan Inc. on Februarry 8,2012. They have visited the office area,the production workshop and...Read more »
